Discover the critical insights from Illumina, Inc.'s 8-K report filed on October 30, 2025. Stay informed about significant events impacting ILMN stock.
Explore Illumina, Inc.'s Q2 2025 financial report showcasing a recovery in net income, strategic R&D investments, and ongoing challenges. Recommendation: Hold.
Explore Illumina, Inc.'s 8-K filing from July 31, 2025, including vital company info, stock data, and structured reporting insights.
Explore Illumina, Inc.'s latest 8-K filing detailing significant events on June 22, 2025. Stay informed with crucial insights for investors and analysts.
Explore Illumina, Inc.'s 8-K filing from May 21, 2025, detailing crucial, time-sensitive updates for investors.
Explore Illumina's Q1 2025 financial performance, revealing $947M revenue, $131M net income, and strategic insights post-GRAIL spin-off. Key trends and future outlook included.
Discover crucial updates from Illumina, Inc. in their 8-K report filed on May 8, 2025, impacting shareholders and stakeholders.
Explore Illumina, Inc.'s 8-K report filed on March 10, 2025, detailing significant corporate events. Key stock info and SEC details included.
Explore Illumina, Inc.'s March 25, 2025, 8-K report detailing significant corporate changes and stock information. Essential for investors and analysts monitoring regulatory compliance.
Explore Illumina, Inc.'s latest 8-K filing report detailing important updates and regulatory information effective March 24, 2025. Stay informed on ILMN's corporate developments!
Explore Illumina, Inc.'s Q4 2024 financial results, revealing $3.99B revenue, $1.22B net loss, and GRAIL segment challenges. Key insights and future outlook provided.
Explore Illumina, Inc.'s 8-K/A filing detailing amendments, future reporting dates, and SEC compliance. Stay informed about stock updates and corporate transparency.